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Abstract
Background: Mycobacterium tuberculosis, the tuberculosis (TB) pathogen, despite a low level of genetic diversity,
has revealed a high variety of biological and epidemiological characteristics linked to their lineages, such as
transmissibility, fitness and propensity to acquire drug resistance. This has important implications for the
epidemiology of TB. We conducted this first countrywide cross-sectional study to identify the prevalent M.
tuberculosis lineages and to assess their epidemiological associations and their relation to drug resistance. The study
was conducted among isolates acquired in reference hospitals across Vietnam. Isolates with drug susceptibility
testing profiles were identified for their lineages by spoligotyping. Logistic regression was used to investigate the
association of M. tuberculosis lineages with location, age and sex of the patients and drug resistance levels.
Results: Results showed that the most prevalent lineage was Beijing (55.4 %), followed by EAI (27.5 %), T (6.4 %),
LAM (1.3 %), Haarlem (1 %) and Zero type (0.3 %). The proportion of Beijing isolates in the North (70.4 %) and the
South (68 %) was higher than in the Centre (28 %) (OR = 1.7 [95 % CI: 1.4–2.0], p < 0.0001), whereas the proportion
of EAI isolates in the North (7.1 %) and the South (17 %) was much lower compared with the Centre (59 %)
(OR = 0.5 [95 % CI: 0.4–0.6], p < 0.0001). Overall, Beijing isolates were the most likely to be drug-resistant and EAI
isolates were the least likely to be drug-resistant, except in the South of Vietnam where EAI is also highly
drug-resistant. The proportion of Beijing isolates was significantly higher (p < 0.01), and the proportion of EAI
isolates was significantly lower (p < 0.05) in younger patients. The proportion of drug-resistance was higher in
isolates collected from male patients and from patients in the middle age groups.
Conclusions: The findings suggest ongoing replacement of EAI lineage, which is mainly more drug-susceptible
with highly drug-resistant Beijing lineage in all studied regions of Vietnam. Male patients of working ages should be
the focus for better control to prevent the emergence of drug-resistant TB.
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Background
Drug resistant tuberculosis (TB) is one of the main chal-
lenges for TB control worldwide due to the emergence
of multi-drug resistant (MDR) Mycobacterium tubercu-
losis [1]. Globally, during the period 1994 to 2010, 3.4 %
of new and 19.8 % of retreated TB cases was estimated
to be MDR-TB (resistant to isoniazid and rifampicin, the
two most potent first-line drugs) [2]. In 2014, an esti-
mated 480,000 people developed MDR-TB. By 2015, 105
countries had reported cases of extensively drug-
resistant TB (XDR-TB) defined as MDR-TB plus resist-
ance to at least a fluoroquinolone and an injectable
second-line drug. This problem, among others, has led
to a reduction in treatment success rate [3].
Extensive molecular studies of M. tuberculosis, the TB
pathogen, have revealed a very low level of genetic diver-
sity [4]. Nevertheless, the genotypic variation, especially
the bacterial lineages, is associated with variation in
transmission capacity and in the propensity to acquire
drug resistance [5–9]. This means that regional variation
in the prevalence of specific lineages or sub-lineages can
have consequences for the observed epidemiology of TB.
Studies showed that Beijing genotypes have been emer-
ging in Vietnam and elsewhere [10–13]. These geno-
types are known to be associated with high prevalence
of drug resistance [12, 14–16] and high rates of disease
transmission [10]. It is feared that these genotypes will
spread further in the coming years and influence the de-
velopment of the TB epidemic [7, 11, 13, 14, 16–20].
In Vietnam, the National TB Control Program has re-
ported that the prevalence of TB was higher in the
South of the country (256/100 000), than in the North
(162/100 000) and the Center (152/100 000) [21]. Our
previous study found that Beijing lineage was the most
prevalent in Northern Vietnam, especially in urban areas
[10]. Based on genotyping and epidemiological traits, we
suggested that strains of this lineage have been imported
and spread within urban areas and from urban to rural
areas. This spread of Beijing is potentially a major
concern, because among other reasons, it may cause the
increase of drug-resistant TB. The second most preva-
lent lineage was EAI lineage, and more particularly
EAI4-VNM sub-lineage, which is specific to Vietnam
[10, 14]. This sub-lineage was found more commonly in
isolates taken from patients in rural, compared with
urban, areas [10]. These findings imply that the genetic
spectrum of M. tuberculosis isolates in Vietnam is not
only distinct from that reported in other nations, but
also varies within the country.
TB reference hospitals are at the highest level of TB care
in Vietnam, where patients from lower levels of the
health-care system are referred for management of treat-
ment failures or recurrent TB. As a consequence of this
role, these hospitals have a high concentration of patients
with drug-resistant TB. We conducted this cross-sectional
study in isolates acquired from these hospitals in three
main regions to investigate the prevalence of M. tubercu-
losis lineages and their relation to drug resistance in
reference hospitals across Vietnam. This molecular epi-
demiological study is the first investigation of the associ-
ation between M. tuberculosis lineages/sub-lineages and
drug resistance at a country level in Vietnam.
Methods
Sample collection
We acquired 300M. tuberculosis isolates for which drug
susceptibility testing (DST) profiles for the four first-line
drugs rifampicin (RMP), isoniazid (INH), streptomycin
(SM) and ethambutol (EMB) were available, from 3 TB ref-
erence hospitals in North (National Lung Hospital), South
(Pham Ngoc Thach Hospital) and Centre (Hue Central
Hospital) of Vietnam (100 isolates per hospital). The iso-
lates had been collected from patients with treatment fail-
ure or recurrent TB during the period 2008 to 2009. In
each hospital, the first isolate was selected randomly and
the next 99 samples were then collected from consecutive
patients (see study population in Fig. 1). During the study
period, the TB reference laboratories of the National Lung
Hospital and Pham Ngoc Thach Hospital were accredited
by the World Health Organization through an External
Quality Assurance program implemented by the regional
supranational laboratory based in Adelaide, Australia.
These laboratories obtained ISO 15189:2007 accreditation
in 2010. Samples collected for the study from Hue Central
Hospital were sent to the TB reference laboratory at the
National Lung Hospital for DST.
M. tuberculosis lineage identification
All isolates, including the control strains M. tuberculosis
H37Rv and M. bovis BCG P3, were typed by spoligotyp-
ing with a 43-spacer-membrane as previously described
[22, 23]. The results were entered into the international
database “SITVITWEB” (http://www.pasteur-guadelou-
pe.fr:8081/SITVIT_ONLINE/) [24], in order to identify
spoligotypes and phylogenetic lineages. Lineage/sub-
lineage of isolates for which the spoligotypes not found
in the SITVITWEB database was defined using SPOT-
CLUST (http://tbinsight.cs.rpi.edu/run_spotclust.html)
[25], and revised by MIRU-VNTRplus (http://www.miru-
vntrplus.org/MIRU/index.faces) [26].
Data analyses
Logistic regression was used to investigate the associ-
ation of M. tuberculosis lineages with location, age and
sex of the patients and drug resistance levels. Each of
these variables was considered as a potential confounder
for the main effect of the other variables. Interactions
between variables were tested when biologically
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meaningful. Polynomial regressions were tested in order
to consider potential non-linear relationships in the logit
function. All the statistical analyses were performed in R
(R Development Core Team, 2010) and SAS version 9.3
(SAS Institute, Cary, NC).
Results
Age and sex distribution of patients whose isolates were
included
After adjusting for region and M. tuberculosis lineage, it
was apparent that the male-to-female ratio differed with
age. The proportion of males was higher in patients of
working age (25 to 64 years) and lower in the younger
and older patients (p < 0.001, Fig. 2). The overall male-
to-female ratio was 2.4 (71 % vs. 29 %).
M. tuberculosis lineages at the regional reference
hospitals
Two isolates showed no band on spoligotyping even
after repeated experiments. Among the other 298 iso-
lates, we identified 7 main lineages with 13 sub-lineages
(Table 1). Beijing was the most prevalent lineage (165
isolates, 55.4 %). The second most prevalent lineage was
EAI (82 isolates, 27.5 %). Only 27 isolates (9.0 %) were
of other lineages, including T (19 isolates, 6.4 %), LAM
(4 isolates, 1.3 %), Haarlem (3 isolates, 1 %) and Zero (1
isolate, 0.3 %). We found 24 isolates (8.0 %) of undesig-
nated spoligotypes (U) (their lineage could not be identi-
fied) (Table 1 and Additional file 1).
The proportions of Beijing isolates were higher in the
North (70.4 %) and the South (68 %) than in the Centre
(28 %) (OR = 1.7 [95 % CI: 1.4–2.0], p < 0.0001), whereas
the proportion EAI isolates in the North (7.1 %) and the
South (17 %) was much lower than in the Centre (59 %)
(OR = 0.5 [95 % CI: 0.4–0.6], p < 0.0001). The proportions
of isolates belonging to lineages other than Beijing and EAI
lineages were not significantly different between the re-
gions (Tables 1 and 2). Among EAI isolates, those of EAI4-
VNM and EAI5 sub-lineages accounted for the majority.
In the North and the South, EAI4-VNM sub-lineage was
more prevalent than EAI5 (85.7 % and 64.7 % vs. 14.3 %
and 23.5 %, respectively), but in the Centre, this lineage did
not predominate compared to EAI5 (46.6 % vs. 51.7 %).
After adjusting for gender and region, the proportion of
Beijing isolates remained significantly higher (p < 0.01) and
the proportion of EAI isolates significantly lower (p < 0.05) in
patients of younger ages. No age trends were observed for the
proportions of isolates belonging to lineages other than
Beijing and EAI. Figure 3 shows the distribution of M.
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Fig. 1 Study population. Note: ref.: reference, MTB: M. tuberculosis, DR: drug resistance
Fig. 2 The proportion of male patients by age correcting for
location and M.tuberculosis lineage. Note: The line is the logistic
model prediction together with 95 % CI (shaded area)
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studied regions. These age differentials in the distribution of
lineages did not significantly differ between regions (p > 0.9
for Beijing lineage and p > 0.2 for EAI lineage).
Drug resistance of M. tuberculosis lineages at the regional
reference hospitals
The proportions of isolates that were resistant to RMP,
INH, SM and EMB among the M. tuberculosis isolates
were 24.5 %, 39.6 %, 42.6 % and 16.8 %, respectively.
MDR isolates was found in 23.8 % of the total. All but
two isolates that were resistant to RMP were also resist-
ant to INH (71 isolates). The proportions of isolates that
were resistant to RMP, INH, SM and EMB were
significantly lower in the Centre (6 %, 12 %, 14 % and
4 %, respectively) than in the two other regions, which
did not significantly differ from each other (49.0 %,
28.6 %, 56.1 % and 23.5 % in the North and 58.0 %,
39.0 %, 58.0 % and 23.0 % in the South) (Tables 3 and 4).
Overall, Beijing isolates were the most commonly resist-
ant ones and EAI isolates were the least commonly resist-
ant ones. This was observed in the North and the Centre,
but not in the South where EAI lineage revealed also a
high level of drug resistance similar to Beijing lineage (Ta-
bles 3 and 4). The EAI4-VNM sub-lineage, which is spe-
cific to Vietnam, had drug resistant proportions similar to
those of the overall EAI lineage. The lineages other than
Beijing and EAI were significantly less resistant than
Beijing but more resistant than EAI (Tables 3 and 4).
After adjustment for lineage, region and sex, the pro-
portions of resistance to the first-line drugs were higher
in patients of the middle age groups (OR (vs. age quin-
tile I) was 1.4–4.2 for age quintiles II, III, IV, Table 5)
and highest for age quintiles III (OR (vs. age quintile I)
was 2.6–4.2, Table 5). There was no significant difference
between age quintile I and V (OR (vs. age quintile I) was
0.6–1.7 for age quintile V, Table 5). After adjustment for
lineage, region and age group, the proportions of MDR
and EMB resistance were significantly higher in men
than in women (Table 5).
Discussion
The M. tuberculosis lineages from reference hospitals
across Vietnam
Our study showed that the most predominant M. tuber-
culosis lineage was Beijing, especially in the North and
the South. Compared with a study conducted in isolates
exhaustively acquired in the same reference hospitals in
the North and the South during 1998 and the first quar-
ter of 1999, which showed Beijing strains were emerging
[11], the proportion of Beijing isolates had increased
(from 54.0 % in previous study to 68.5 % in this study).
As suggested in our previous study, Beijing strains would
have been imported through international exchanges
and migration and spread within urban areas and from
urban to rural areas [10]. The increase in the proportion
of Beijing isolates during the 10 years that separate the
Table 2 Comparison of the proportion of M. tuberculosis lineages at the regional reference hospitals
Lineage Region OR (95 % CI) OR (95 % CI)
North Centre South (North & South) vs. Centre P a North vs. South P a
n (%) n (%) n (%)
Beijing 69 (70.4) 28 (28.0) 68 (68.0) 1.7 (1.4–2.0) <0.0001 1.0 (0.7–1.0) 0.8223
EAI 7 (7.1) 58 (58.0) 17 (17.0) 0.5 (0.4–0.6) <0.0001 1.6 (1.0–2.6) 0.0419
Others 22 (22.5) 14 (14.0) 15 (15.0) 1.1 (0.9–1.4) 0.2570 0.8 (0.5–1.1) 0.1580
a: Logistic regressions, correcting for age and sex of the patients
Table 1 M. tuberculosis lineages and sub-lineages at the
regional reference hospitals
Lineage Sub-lineage Location
Total North Centre South
n (col. %) n (col. %) n (col. %) n (col. %)
Beijing 165 (55.4) 69 (70.4) 28 (28.0) 68 (68.0)
EAI 82 (27.5) 7 (7.1) 58 (58.0) 17 (17.0)
EAI2 2 (0.7) 1 (1.0) 1 (1.0)
EAI2_Manilla 1 (0.3) 1 (1.0)
EAI4_VNM 44 (14.8) 6 (6.1) 27 (27.0) 11 (11.0)
EAI5 35 (11.7) 1 (1.0) 30 (30.0) 4 (4.0)
T 19 (6.4) 11 (11.2) 4 (4.0) 4 (4.0)
T1 14 (4.7) 9 (9.2) 2 (2.0) 3 (3.0)
T2 3 (1.0) 2 (2.0) 1 (1.0)
T3 1 (0.3) 1 (1.0)
T5_RUS1 1 (0.3) 1 (1.0)
LAM 4 (1.3) 2 (2.0) 1 (1.0) 1 (1.0)
LAM10 1 (0.3) 1 (1.0)
LAM9 3 (0.7) 1 (1.0) 1 (1.0) 1 (1.0)
H H3 3 (1.0) 3 (3.1)
Zero 1 (0.3) 1 (1.0)
U 24 (8.0) 6 (6.1) 8 (8.0) 10 (10.0)
Total 298 (100) 98 (100) 100 (100) 100 (100)
The bold numbers are the total numbers of isolates belonging to the M.
tuberculosis lineages presented on the same lines in the first column, equal to
the sum of the numbers of isolates of the sublineages (presented on the
second column) under these lineages
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1998–1999 study and the current one was thus
expected.
The difference in the proportions of Beijing isolates in
the Centre compared with the North and the South can
be explained by the differences in regional characteris-
tics. In particular, the reference hospitals in the North
and the South are located in the two most major and
largest cities of Vietnam, whereas the reference hospital
in the Centre is located in Hue city which is a small city
and more isolated in terms of international exchanges
and migration. This may reflect the rural and urban dis-
parities in the genetic spectrum of M. tuberculosis iso-
lates as previously documented [10].
Our spoligotyping results showed that the M. tubercu-
losis lineages were globally the same in the three re-
gional hospitals, apart from 1 or 2 isolates. The M.
tuberculosis sample in this study was genetically less di-
verse than the sample collected at low-level hospitals in
the Northern plain of Vietnam in our previous study
[10]. In particular, the MANU and X lineages, which
accounted for 2.2 % and 0.8 % respectively in the previ-
ous study, were absent from the isolates collected from
the regional hospitals.
TB that occurs in young patients is likely to be attrib-
utable to recent transmission whereas in older patients
it is more likely to be attributable to reactivation of la-
tent TB that was acquired when the person was young
[27]. Hence, the observed association of M. tuberculosis
lineage distribution with patients’ ages (that is, a higher
proportion of Beijing isolates and a lower proportion of
EAI isolates in younger patients), which is consistent
with previous studies in Vietnam [10, 28], suggests a
progressive replacement of EAI strains with Beijing
strains in all studied regions. As Beijing isolates were less
prevalent and EAI isolates were more predominant in
the Centre compared with the North and the South, this
replacement seems to be less intensive in the Centre. It
is noteworthy that in the regions with more intensive re-
placement, the proportions of EAI5 isolates out of the
total EAI isolates were lower than in the region with less
intensive replacement (14.3 % in the North and 23.5 %
in the South vs. 51.7 % in the Centre). Conversely, the
proportions of EAI4-VNM isolates out of the total EAI
isolates were higher in the regions with more intensive
replacement (85.7 % in the North and 64.7 % in the
South vs. 46.6 % in the Centre). This suggests that the
EAI5 sub-lineage was more prone to be replaced com-
pared with the EAI4-VNM sub-lineage. The replacement
of locally adapted EAI strains with Beijing strains as seen
in this and previous studies suggests, as expected, a par-
ticularly higher fitness of Beijing strains compared to
EAI strains in Vietnam.
The association of M. tuberculosis lineage and
anti-tuberculosis drug resistance in reference hospitals
across Vietnam
The overall proportions of resistance to the four first-
line anti-tuberculosis drugs of the studied M. tubercu-
losis isolates were the highest for SM (42.6 %) and the
lowest for EMB (16.8 %). MDR isolates accounted for
23.8 % of the total. The levels of drug resistance ob-
served in this study were similar to the levels of drug re-
sistance in patients who were being treated for failure or
recurrent TB during the National Drug Resistance sur-
vey, conducted in 2011 [29]. This is consistent with the
strategic role of reference hospitals in the Vietnam Na-
tional TB Program.
As the Vietnam National TB program has been using
GeneXpert for MDR-TB case detection, the high propor-
tion (97.3 %) of INH resistant isolates that are also re-
sistant to RMP in our study suggests that this strategy is
reliable.
Our analysis shows that the prevalence of drug resist-
ance was lower in the Centre than in the rest of the
Fig. 3 Distribution of M. tuberculosis lineages by age at the regional reference hospitals. Note: The lines are the logistic model predictions (corrected
for patients’ gender) of the proportion of Beijing (red), EAI (blue) and lineages other than Beijing and EAI (green) together with 95 % CI (shaded area)
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Total North Centre South
n a (col.%) b n a (col.%) b n a (col. %) b n a (col.%) b
INH All 298 (39.6) 98 (49.0) 100 (12.0) 100 (58.0)
Beijing 165 (53.9) 69 (58.0) 28 (32.1) 68 (58.8)
EAI 82 (14.8) 7 (14.3) 58 (3.5) 17 (52.9)
EAI4_VNM 44 (16.3) 6 (0.0) 27 (3.7) 11 (54.5)
Others 51 (32.7) 22 (31.8) 14 (7.1) 15 (60.0)
RMP All 298 (24.5) 98 (28.6) 100 (6.0) 100 (39.0)
Beijing 165 (34.5) 69 (34.8) 28 (21.4) 68 (39.7)
EAI 82 (9.9) 7 (14.3) 58 (0.0) 17 (41.2)
EAI4_VNM 44 (11.6) 6 (0.0) 27 (0.0) 11 (45.5)
Others 51 (15.4) 22 (13.6) 14 (0.0) 15 (33.3)
SM All 298 (42.6) 98 (56.1) 100 (14.0) 100 (58.0)
Beijing 165 (63.0) 69 (66.7) 28 (42.9) 68 (67.6)
EAI 82 (6.1) 7 (14.3) 58 (0.0) 17 (23.5)
EAI4_VNM 44 (7.0) 6 (0.0) 27 (0.0) 11 (27.3)
Others 51 (34.6) 22 (36.4) 14 (14.3) 15 (53.3)
EMB All 298 (16.8) 98 (23.5) 100 (4.0) 100 (23.0)
Beijing 165 (25.5) 69 (27.5) 28 (14.3) 68 (27.9)
EAI 82 (3.7) 7 (14.3) 58 (0.0) 17 (11.7)
EAI4_VNM 44 (4.6) 6 (0.0) 27 (0.0) 11 (18.1)
Others 51 (9.6) 22 (13.6) 14 (0.0) 15 (13.3)
MDR All 298 (23.8) 98 (28.6) 100 (6.0) 100 (37.0)
Beijing 165 (33.3) 68 (34.8) 28 (21.4) 68 (36.7)
EAI 82 (9.9) 7 (14.3) 58 (0.0) 17 (41.2)
EAI4_VNM 44 (11.6) 6 (0.0) 27 (0.0) 11 (45.5)
Others 51 (15.4) 22 (13.6) 14 (0.0) 15 (33.3)
a:Total number of isolates
b:Proportion of drug resistant isolates
The bold numbers show the total sums and proportions of drug resistance (in bracket) for all isolates, irrespective of their lineages
Table 4 Comparison of dug resistance levels of M. tuberculosis lineages in the different regions
Resistance Region a Lineage b
North Centre vs. North South vs. North Beijing EAI vs. Beijing Others vs. Beijing
OR (95 % CI) OR (95 % CI) OR (95 % CI) OR (95 % CI)
INH 1.0 0.2 (0.1–0.6) 1.6 (0.9–3.0) 1.0 0.2 (0.1–0.6) 0.4 (0.2–0.9)
RMP 1.0 0.2 (0.1–0.6) 1.9 (0.9–3.5) 1.0 0.4 (0.1-0.9) 0.4 (0.2–0.9)
SM 1.0 0.3 (0.1–0.7) 1.3 (0.7–2.5) 1.0 0.1 (0.0–0.2) 0.3 (0.2–0.7)
EMB 1.0 0.2 (0.1–0.7) 1.2 (0.6–2.5) 1.0 0.2 (0.1–0.7) 0.3 (0.1–0.9)
MDR 1.0 0.2 (0.1–0.6) 1.7 (0.9–3.2) 1.0 0.4 (0.2–1.0) 0.4 (0.2–0.9)
a:Logistic regressions correcting for M. tuberculosis lineage, age and sex of the patients
b:Logistic regressions correcting for region, age and sex of the patients
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country and was not significantly different between the
North and the South. This is explained by the lower pro-
portion of Beijing isolates and the higher proportion of
EAI isolates in the Centre than the rest of the country
and the finding that Beijing isolates are more likely to be
drug-resistant than EAI isolates. This finding suggests
that the ongoing replacement of EAI lineage by Beijing
lineage in Vietnam also means a replacement of the
most drug-susceptible strains by highly drug-resistant
strains. Therefore, not withstanding acquired resistance
caused by TB treatment, a higher rate of drug resistant
TB can be foreseen in the near future. The empirical evi-
dence to justify this concern is the increased rate of
MDR-TB, as shown in consecutive National Drug Resist-
ance surveys, from 2.7 % to 4 % among new cases and
from 19 % to 23.3 % in retreatment cases between 2006
and 2011 [21, 22].
In the South, both the Beijing lineage and the EAI
lineage were associated with a high likelihood of being
drug-resistant. This latter lineage was least likely to be
associated with drug resistance in the North and the
Centre. The EAI4-VNM sub-lineage was reported to be
the predominant one (50.7 %) in a study conducted in 3
rural districts in the South of Vietnam [28], with a
prevalence almost twice as high as the one in rural dis-
tricts in the North of Vietnam [10]. In this study EAI/
EAI4-VNM isolates were found to have very different
levels of drug resistance in the three regions. This
lineage/sub-lineage was among the most drug-resistant
lineages in the South but was the most sensitive in the
North and the Centre. This implies that these strains are
also epidemiologically important and need to be moni-
tored, and there would be a higher antibiotic pressure in
the South compared to the North and the Center.
The observation association between male-to-female
ratio and patients’ age for the studied M. tuberculosis
isolates was similar to the finding of the National TB
prevalence survey of Vietnam conducted during 2006–
2007. This survey also showed that the male-to-female
ratio for prevalent TB was higher in patients of working
ages (25 to 64 years) and lower in the younger and older
patients [21]. The high overall male-to-female ratio in
this study is also consistent with findings of the preva-
lence survey and other previous studies in which the
male-to-female ratio was between 2.4–5.1 [10, 14, 21].
These findings demonstrate that the observed gender
difference in this study population is not an artefact of
sample collection from the reference hospitals or related
to gender differences in access to diagnosis and treat-
ment, but it is actually a feature of epidemiology of TB
in Vietnam in general.
For all the tested drugs, the proportions of drug-
resistant isolates were higher in patients of middle age
groups (28–57 years old), highest for patients of 37–46
years old and lower in patients of younger and older ages.
Furthermore, the proportions of MDR and EMB resistant
strains were significantly higher in men compared to
women. These findings are different from those of a study
conducted in Georgia among hospitalized TB patients,
which failed to show any association between drug resist-
ance and age [30]. This study also showed that female
patients were more at risk of having MDR-TB than male
patients. These differences suggest that control strategies
should be adapted for different settings. Studies in devel-
oping countries showed that male TB patients tend to
have poorer treatment compliance than female ones due
to neglected treatment, alcoholism and fear of losing jobs,
especially the ones of the middle age groups [31, 32]. This
problem could lead to higher level of drug resistance
among male TB patients. In order to achieve better con-
trol over the emergence of MDR-TB in Vietnam, it is im-
portant to focus on improving treatment compliance
among male patients of working ages.
Conclusions
This first study on the molecular epidemiology of TB in
TB reference hospitals across regions of Vietnam shows
that Beijing and EAI lineages were the most
Table 5 Association of the drug resistance levels of M. tuberculosis with gender and age of the patients by logistic regression
analysis
Resistance Sex (Male vs. female) b Age quintile a, c
OR (95 % CI) P II vs. I III vs. I IV vs. I V vs. I P
OR (95 % CI) OR (95 % CI) OR (95 % CI) OR (95 % CI)
INH 1.5 (0.8–2.8) 0.25 4.1 (1.8–9.6) 4.2 (1.7–10.3) 3.2 (1.4–7.6) 0.8 (0.3–2.2) 0.0002
RMP 2.4 (1.2–4.8) 0.01 2.9 (1.1–7.3) 2.9 ((1.1–7.6) 2.5 (1.0–6.5) 1.1 (0.3–3.6) 0.08
SM 1.5 (0.8–3.0) 0.2 2.0 (0.9–4.6) 2.6 (1.0–6.4) 2.1 (0.9–5.1) 0.6 (0.2–1.6) 0.02
EMB 2.4 (1.1–5.1) 0.02 3.8 (1.3–10.8) 3.8 (1.3–11.4) 1.4 (0.5–4.5) 1.7 (0.5–6.2) 0.04
MDR 2.5 (1.3–4.9) 0.009 2.6 (1.0–6.7) 2.9 (1.1–7.6) 2.3 (0.9–5.9) 1.1 (0.3–3.5) 0.11
a: I, II, III, IV and V: age quintile, the cut-points for age quintiles are 2 (min), 28, 37, 46, 57 and 86 (max)
b: Correcting for region, lineage and age
c: Correcting for region, lineage and sex
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epidemiologically important ones, not only because they
are the most predominant lineages/sub-lineages but also
because they are the most likely to be drug-resistant line-
ages in one (in the South for EAI lineage) or all regions of
Vietnam (for Beijing lineage). The replacement of EAI
strains by Beijing strains, especially in the North and in
the Centre can be expected to lead to a higher prevalence
of drug resistant TB in Vietnam in the near future. Male
patients of working ages should be particularly targeted in
order to prevent the emergence of drug resistant TB.
Additional file
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